Adjust Font Size:

Press Releases

Advanced Cell Technology’s Chairman and CEO, William M. Caldwell, IV, to Present at EQUITIES 56th Anniversary Spring Conference 2007

To Discuss Latest Company Developments and Trends in Human Embryonic Stem Cell Research & Development Sector, on April 20, 2007

Alameda, CA, - [April 20, 2007] - Advanced Cell Technology, Inc.'s (OTCBB: ACTC) Chairman and Chief Executive Officer, William M. Caldwell, IV, has accepted an invitation to present at EQUITIES Magazine's 56th annual Spring Conference at the Yale Club in New York City. Mr. Caldwell's new presentation, scheduled for 11:30AM EST on Friday, April 20, 2007, will include an update on the company's achievements and plans, particularly in light of recent political developments, as general information on trends in human embryonic stem cell research and the emerging field of regenerative medicine.

A live audio web cast of this new presentation can be viewed by visiting "www.visualwebcaster.com.":http://www.visualwebcaster.com/event.asp?id=39192

To download PDF version, please visit "advancedcell.com/conference-presentations/":http://www.advancedcell.com/conference-presentations/


About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit "http://www.advancedcell.com":http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the Annual Report on Form 10-KSB for the year ended December 31, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

Contact:

The Investor Relations Group
Investors: James Carbonara & Joseph Kessler - 212-825-3210
Media: Bill Douglass - 212-825-3210

Source: Advanced Cell Technology, Inc.

Press Contact



212-825-3210

Download PDF


ACTC-EQUITIES-Release.pdf

To view PDF Files, you must have Acrobat Reader.

Download Adobe Acrobat